Skip to content

Psilocybin: all studies

Page 429 of 440: studies 4,281 to 4,290 of 4,392, newest first. Back to the psilocybin overview

Research

Khat and mushrooms associated with psychosis

The World Journal of Biological Psychiatry 2004 Roman J Nielen, Frank Mma van der Heijden, S. Tuinier et al. 42 citations

OBJECTIVE: This paper describes two cases with khat- and two with psilocybin-induced psychoses and draws attention to the medical and social consequences of the use of these drugs. METHOD: Two male patients are presented who developed relapsing and short-lasting psychotic episodes after chewing kath leaves. In addition, two male patients are reported who showed an acute exacerbation of...

DOI: 10.1080/15622970410029908 (opens in new tab) Psychosis Traditional medicine

Champignons hallucinogènes d'Europe et des Amériques : mise au point mycologique et toxicologique

Annales de Toxicologie Analytique 2004 Régis Courtecuisse, Marc Deveaux 7 citations

L'usage récréatif des champignons hallucinogènes est maintenant bien établi, en Europe et en Amérique du Nord. En Amérique Centrale, ils sont également utilisés dans un but spirituel et religieux. Les principes actifs à noyau indolique sont la psilocine et la psilocybine. Le syndrome hallucinogène causé par quelques milligrammes de psilocybine est très classique, avec dépersonnalisation,...

Out of Harm's Way?: Illicit Drug Use, Medicalization and the Law

The British Journal of Criminology October 1, 2003 M. Shiner 14 citations

Although British drugs policy has become increasingly contested, debate in this area has continued along well-established lines. Recent reviews, including those conducted by the independent inquiry into the Misuse of Drugs Act and the Select Committee on Home Affairs, have called for reform largely on the basis of the established medicalized philosophy. While the related notions of...

Phylogenetic relationship of psychoactive fungi based on the rRNA gene for a large subunit and their identification using the TaqMan assay.

Chemical & pharmaceutical bulletin June 1, 2003 Takuro Maruyama, Kazumasa Yokoyama, Yukiko Makino et al.

"Magic mushrooms" (MMs) are psychoactive fungi containing the and Psychotropics Control Law in Japan. Because there are many kinds of MMs and they are often sold even as dry powders in local markets, it is very difficult to identify the original species of the MMs by morphological observation. Therefore, we investigated the rRNA gene for a large subunit (LSU) of several MMs to classify them by...

DOI: 10.1248/cpb.51.710 (opens in new tab) Full text (opens in new tab) Agaricales Rna, fungal Hallucinogens Phylogeny +5

Halluzinogene, Amphetamine und Entactogene

Therapeutische Umschau June 1, 2003 Franz X. Vollenweider, M. F. I. Vollenweider-Scherpenhuyzen 3 citations

MDMA ("Ecstasy") and its analogues such as MDE and MDA are amphetamine derivatives reported to produce an altered state with emotional overtones. Since more than ten years, ecstasy is after cannabis the most frequently used recreational drug by young adults, particularly in the so-called techno-scene. However, according to a recent survey there is an increasing trend for a revival of classic...

The Analysis of Controlled Substances

Analytical techniques in the sciences March 28, 2003 M D Cole 39 citations

Series Preface. Preface. Acronyms, Abreviations and Symbols. About the Author. Introduction to Drug Trends, Control, Legislation and Analysis. Amphetamine and Related Compounds. The Analysis of LSD. Cannabis sativa and Products. Diamorphine and Heroin. Cocaine. Products from Catha edulis and Lophophora williamsii. The Analysis of Psilocybin and Psilocin from Fungi. The Analysis of Controlled...

Síndromes neurológicos asociados con el consumo de plantas y hongos con componente tóxico (II). Hongos y plantas alucinógenos, micotoxinas y hierbas medicinales

Revista de Neurología 2003 Francisco Javier Carod-Artal 18 citations

INTRODUCTION: A wide range of fungi and medicinal herbs, rich in hallucinogenic substances and widely used for mystic and medicinal purposes, can give rise to neurotoxic symptoms. DEVELOPMENT: We review the toxic syndromes that can arise from the ingestion of hallucinogenic fungi, cacti and plants, together with descriptions of cases of acute poisoning resulting from the use of medicinal herbs...

Psychoactive Drugs and Quality of Life

TheScientificWorldJournal 2003 Søren Ventegodt, Joav Merrick 65 citations

This study was performed on a representative sample of the Danish population in order to investigate the connection to the use of psychoactive drugs and quality of life (QOL) by way of a questionnaire-based survey. The questionnaire was mailed in February 1993 to 2,460 persons aged between 18 and 88, randomly selected from the CPR (Danish Central Register), and 7,222 persons from the Copenhagen...

Psychotropic Drugs in Developmental Mushrooms: A Case Study Review

Journal of Forensic Sciences November 1, 2002 Stefanie Groß 10 citations

Abstract Psilocyn and psilocybin can be identified in different stages of developing psilocybe mushrooms. Knowing the various stages of the mushroom development can be useful when receiving evidence from illicit mushroom growing operations. Exhibits from three separate cases were submitted to the drug analysis section of the Minnesota Bureau of Criminal Apprehension Forensic Science Laboratory....

DOI: 10.1520/jfs15564j (opens in new tab) Suicide prevention Poison control Injury prevention Medical emergency

5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens.

Pharmacology, Biochemistry, and Behavior May 2002 Richard A. Rabin, Meredith J. Regina, Mireille M Doat et al.

The role of 5-HT2A-mediated stimulation of phosphoinositide hydrolysis in the discriminative effects of hallucinogens was investigated in PC12 cells stably expressing the rat 5-HT2A receptor (PC12-5-HT2A cells). The hallucinogenic compounds, D-lysergic acid diethylamide (LSD), (-)2,5-dimethoxy-4-methylamphetamine (DOM), psilocybin, N,N-dimethyltryptamine (DMT), 5-methoxy-N,N-dimethyltryptamine...